CA2286303A1 - 20 human secreted proteins - Google Patents

20 human secreted proteins Download PDF

Info

Publication number
CA2286303A1
CA2286303A1 CA002286303A CA2286303A CA2286303A1 CA 2286303 A1 CA2286303 A1 CA 2286303A1 CA 002286303 A CA002286303 A CA 002286303A CA 2286303 A CA2286303 A CA 2286303A CA 2286303 A1 CA2286303 A1 CA 2286303A1
Authority
CA
Canada
Prior art keywords
polypeptide
seq
sequence
cells
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002286303A
Other languages
English (en)
French (fr)
Inventor
Craig A. Rosen
Steven M. Ruben
Guo-Liang Yu
Jian Ni
Ping Feng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2286303A1 publication Critical patent/CA2286303A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002286303A 1997-04-08 1998-04-07 20 human secreted proteins Abandoned CA2286303A1 (en)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US4275497P 1997-04-08 1997-04-08
US4272797P 1997-04-08 1997-04-08
US4272697P 1997-04-08 1997-04-08
US4282597P 1997-04-08 1997-04-08
US4272897P 1997-04-08 1997-04-08
US4818497P 1997-05-30 1997-05-30
US4807097P 1997-05-30 1997-05-30
US4806897P 1997-05-30 1997-05-30
US60/042,727 1997-05-30
US60/048,184 1997-05-30
US60/042,754 1997-05-30
US60/042,726 1997-05-30
US60/042,825 1997-05-30
US60/048,068 1997-05-30
US60/042,728 1997-05-30
US60/048,070 1997-05-30
PCT/US1998/006801 WO1998045712A2 (en) 1997-04-08 1998-04-07 20 human secreted proteins

Publications (1)

Publication Number Publication Date
CA2286303A1 true CA2286303A1 (en) 1998-10-15

Family

ID=27574292

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002286303A Abandoned CA2286303A1 (en) 1997-04-08 1998-04-07 20 human secreted proteins

Country Status (5)

Country Link
EP (1) EP0974058A2 (de)
JP (1) JP2001521383A (de)
AU (1) AU6952998A (de)
CA (1) CA2286303A1 (de)
WO (1) WO1998045712A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018022A1 (en) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 52 human secreted proteins
WO1999018208A1 (en) * 1997-10-02 1999-04-15 Human Genome Sciences, Inc. 101 human secreted proteins
EP1445316A1 (de) * 1997-10-02 2004-08-11 Human Genome Sciences, Inc. Neues sekretiertes Protein
US7291712B2 (en) * 1998-06-25 2007-11-06 Genentech, Inc. Interleukin-8 homologous polypeptides and therapeutic uses thereof
AU5447899A (en) * 1998-09-03 2000-03-27 Takeda Chemical Industries Ltd. Novel protein and process for producing the same
AU2757500A (en) * 1999-02-10 2000-08-29 Human Genome Sciences, Inc. 33 human secreted proteins
WO2000055175A1 (en) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. 50 human secreted proteins
AU3885400A (en) * 1999-03-23 2000-10-09 Human Genome Sciences, Inc. 48 human secreted proteins
EP1171626A4 (de) * 1999-03-26 2002-10-30 Human Genome Sciences Inc 50 humane sekretierte proteine
AU3632900A (en) * 1999-03-26 2000-10-16 Human Genome Sciences, Inc. 50 human secreted proteins
JP2003500014A (ja) * 1999-03-26 2003-01-07 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ５０個のヒト分泌タンパク質
CA2370562A1 (en) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 49 human secreted proteins
JP2003524402A (ja) * 1999-05-14 2003-08-19 キュラジェン コーポレイション 新規のポリヌクレオチドおよびそれによりコードされるポリペプチド
WO2000078802A2 (en) * 1999-06-23 2000-12-28 Curagen Corporation Secreted polypeptides and corresponding polynucleotides
US7001766B2 (en) 1999-07-20 2006-02-21 Curagen Corporation Nucleic acid sequences encoding human angiopoietin-like polypeptides
AU6229100A (en) * 1999-07-20 2001-02-05 Curagen Corporation Polypeptides and polynucleotides encoding same
CA2381396A1 (en) * 1999-08-11 2001-02-15 Curagen Corporation Polynucleotides and polypeptides encoded thereby
CA2384749A1 (en) * 1999-09-13 2001-03-22 Curagen Corporation Novel human proteins, polynucleotides encoding them and methods of using the same
ES2283324T3 (es) 1999-11-02 2007-11-01 Drk-Blutspendedienst Baden-Wurttemberg-Hessen Gemeinnutzige Gmbh Estructura molecular del locus rhd negativo.
US20070087342A1 (en) * 2000-01-14 2007-04-19 Incyte Corporation Secreted proteins
AU2001241709A1 (en) * 2000-02-24 2001-09-03 Incyte Genomics, Inc. Molecules for disease detection and treatment
CA2418496A1 (en) * 2000-02-24 2001-08-30 Incyte Genomics, Inc. Secretory polypeptides and corresponding polynucleotides
WO2001062927A2 (en) * 2000-02-24 2001-08-30 Incyte Genomics Inc Polypeptides and corresponding polynucleotides for diagnostics and therapeutics
CA2419943A1 (en) * 2000-09-05 2002-03-14 Incyte Genomics, Inc. Secretory molecules
WO2002020754A2 (en) * 2000-09-05 2002-03-14 Incyte Genomics, Inc. Molecules for diagnostics and therapeutics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby

Also Published As

Publication number Publication date
WO1998045712A2 (en) 1998-10-15
WO1998045712A3 (en) 1998-12-03
EP0974058A2 (de) 2000-01-26
AU6952998A (en) 1998-10-30
JP2001521383A (ja) 2001-11-06

Similar Documents

Publication Publication Date Title
EP1015477B1 (de) 32 Humane sekretierte Proteine
US7482442B2 (en) HEMCM42 nucleic acids
WO1999002546A1 (en) 123 human secreted proteins
CA2286303A1 (en) 20 human secreted proteins
US20060188962A1 (en) 19 human secreted proteins
EP1040117A1 (de) 110 menschliche sekretierte proteines
EP1044211A1 (de) 36 menschliche sekretierte proteine
EP1019091A1 (de) 50 menschliche sekretierte proteine
WO1999024836A1 (en) 125 human secreted proteins
WO1999019339A1 (en) 53 human secreted proteins
WO1999022243A1 (en) 148 human secreted proteins
WO1999010363A1 (en) 29 human secreted proteins
WO1999006423A1 (en) 83 human secreted proteins
WO1999018208A1 (en) 101 human secreted proteins
US20070238664A1 (en) 70 Human Secreted Proteins
EP1333092A2 (de) 28 menschlich sekretierte Proteine
EP1336656A2 (de) 20 menschliche sekretierte Proteine
EP1352962A1 (de) 186 humane sekretierte Proteine
EP1394252A2 (de) 70 Humane sekretierte Proteine
EP1557425A2 (de) Humanes sekeretiertes Protein
EP1439189A2 (de) 86 sekretierte menschliche Proteine
EP1464653A1 (de) Humanes sekretiertes Protein
EP1445316A1 (de) Neues sekretiertes Protein
EP1346999A2 (de) Humane sekretierte Proteine
EP1428833A2 (de) 207 menschliche sekretierte Proteine

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead